EFFICACY OF LURASIDONE IN ANTIPSYCHOTIC-NAIVE ADOLESCENTS WITH SCHIZOPHRENIA: POST-HOC ANALYSIS OF A 6-WEEK, RANDOMIZED, PLACEBO-CONTROLLED STUDY

被引：1
|
作者：
Correll, Christoph [1 ]
Goldman, Robert [2 ]
Tocco, Michael [2 ]
Pikalov, Andrei [2 ]
Hsu, Jay [2 ]
Loebel, Antony [2 ]
机构：
[1] Hofstra North Shore LIJ Sch Med, Zucker Hillside Hosp, Hempstead, NY USA
[2] Sunovion Pharmaceut Inc, Marlborough, MA USA
来源：
SCHIZOPHRENIA BULLETIN | 2019年 / 45卷
关键词：
D O I：
10.1093/schbul/sbz018.518
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
F106
引用
收藏
页码：S293 / S294
页数：2
相关论文
共 50 条
  • [1] EFFICACY OF LURASIDONE IN ANTIPSYCHOTIC-NAIVE VS. PREVIOUSLY TREATED ADOLESCENTS WITH SCHIZOPHRENIA: POST-HOC ANALYSIS OF A 6-WEEK, RANDOMIZED, PLACEBO-CONTROLLED STUDY
    Correll, C. U.
    Tocco, M.
    Pikalov, A.
    Goldman, R.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2021, 55 (1_SUPPL): : 103 - 103
  • [2] Efficacy and Safety of Lurasidone in Adolescents with Schizophrenia: A 6-Week, Randomized Placebo-Controlled Study
    Goldman, Robert
    Loebel, Antony
    Cucchiaro, Josephine
    Deng, Ling
    Findling, Robert L.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2017, 27 (06) : 516 - 525
  • [3] Lurasidone in the treatment of schizophrenia: a 6-week, placebo-controlled study
    Ogasa, Masaaki
    Kimura, Tatsuya
    Nakamura, Mitsutaka
    Guarino, John
    PSYCHOPHARMACOLOGY, 2013, 225 (03) : 519 - 530
  • [4] Lurasidone in the treatment of schizophrenia: a 6-week, placebo-controlled study
    Masaaki Ogasa
    Tatsuya Kimura
    Mitsutaka Nakamura
    John Guarino
    Psychopharmacology, 2013, 225 : 519 - 530
  • [5] Efficacy and safety of lurasidone in adolescents and young adults with schizophrenia: A pooled post hoc analysis of double-blind, placebo-controlled 6-week studies
    Costamagna, Isabella
    Calisti, Fabrizio
    Cattaneo, Agnese
    Hsu, Jay
    Tocco, Michael
    Pikalov, Andrei
    Goldman, Robert
    EUROPEAN PSYCHIATRY, 2021, 64 (01)
  • [6] EFFICACY OF LURASIDONE IN ANTIPSYCHOTIC-NAIVE VS. PREVIOUSLY TREATED ADOLESCENTS WITH SCHIZOPHRENIA: POST-HOC ANALYSIS OF A TWO YEAR, OPEN-LABEL STUDY
    Correll, C. U.
    Tocco, M.
    Pikalov, A.
    Goldman, R.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2021, 55 (1_SUPPL): : 102 - 102
  • [7] EFFICACY OF LURASIDONE IN ANTIPSYCHOTIC-NAIVE VERSUS PREVIOUSLY TREATED ADOLESCENTS WITH SCHIZOPHRENIA: POST-HOC ANALYSIS OF A 2-YEAR, OPEN-LABEL STUDY
    Correll, C. U.
    Tocco, M.
    Goldman, R.
    Pikalov, A.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2022, 56 (1_SUPPL): : 206 - 206
  • [8] Lurasidone for the treatment of acutely psychotic patients with schizophrenia: A 6-week, randomized, placebo-controlled study
    Nasrallah, Henry A.
    Silva, Robert
    Phillips, Debra
    Cucchiaro, Josephine
    Hsu, Jay
    Xu, Jane
    Loebel, Antony
    JOURNAL OF PSYCHIATRIC RESEARCH, 2013, 47 (05) : 670 - 677
  • [9] Efficacy and Safety of Blonanserin Oral Tablet in Adolescents with Schizophrenia: A 6-Week, Randomized Placebo-Controlled Study
    Saito, Takuya
    Sugimoto, Saori
    Sakaguchi, Reiko
    Nakamura, Hiroshi
    Ishigooka, Jun
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2022, 32 (01) : 12 - 23
  • [10] LONG-TERM EFFICACY OF LURASIDONE IN ANTIPSYCHOTIC-NAIVE VERSUS ANTIPSYCHOTIC-EXPOSED ADOLESCENTS WITH SCHIZOPHRENIA: POST-HOC ANALYSIS OF A 2-YEAR, OPEN-LABEL STUDY
    Correll, Christoph U.
    Goldman, Robert S.
    Tocco, Michael
    Pikalov, Andrei A.
    Hsu, Jay
    Loebel, Antony
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2019, 58 (10): : S236 - S236
12345